| Raven Julius Sandifer Jr, PHARMD | |
|
2323 N Lake Dr, Milwaukee, WI 53211-4508 | |
| (414) 291-1068 | |
| (414) 291-1073 |
| Full Name | Raven Julius Sandifer Jr |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2323 N Lake Dr, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013274398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15167-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Raven Julius Sandifer Jr, PHARMD 2323 N Lake Dr, Milwaukee, WI 53211-4508 Ph: (414) 291-1068 | Raven Julius Sandifer Jr, PHARMD 2323 N Lake Dr, Milwaukee, WI 53211-4508 Ph: (414) 291-1068 |
News Archive
SDI (Strategic Diagnostics Inc.), a leading provider of biotechnology-based products and services for a broad range of life science, food safety, and industrial applications, today announced it has been selected again by Science Applications International Corporation - Frederick (SAIC-F) to develop monoclonal antibodies for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative (CPTC: http://proteomics.cancer.gov).
After an extensive search for a Stage 2 Certified EHR with a clinical focus in the post-acute and long term care arena, Extended Care Specialists has selected gEHRiMed™ as their EHR of choice.
Republican candidates in states that have had troubled exchange rollouts plan to campaign on those problems in gubernatorial and state legislative races later this year, reports The New York Times. Other news outlets report on developments in Kentucky, Oregon, Rhode Island, Maryland, Minnesota, Connecticut and Pennsylvania.
Allergan plc announced today the publication of the positive results of the Phase III trials of VIBERZITM C IV (eluxadoline) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in the January 21 issue of The New England Journal of Medicine.
The Centers for Disease Control and Prevention (CDC) today implemented a new system for providing travelers with guidance about potential health hazards and the steps they can take to protect themselves when traveling abroad. The new system makes it easier for the public to understand what their risks may be during an emerging public health crisis and what they can do to protect themselves.
› Verified 5 days ago
Robin L Berk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1134 W North Ave, Third Floor, Milwaukee, WI 53205 Phone: 414-727-3005 | |
Kevin Bozymski, PHARMD, BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1155 N Mayfair Rd, Milwaukee, WI 53226 Phone: 414-955-8950 | |
Hanna Dehnert, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3003 W Good Hope Rd, Milwaukee, WI 53209 Phone: 414-540-9236 | |
Belaynesh Dejene Feleke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5929 W Lisbon Ave, Milwaukee, WI 53210 Phone: 414-442-9233 | |
Ting Chen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3030 W Villard Ave, Milwaukee, WI 53209 Phone: 414-536-3378 | |
Matthew Olson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2920 W Dakota St, Milwaukee, WI 53215 Phone: 262-957-8239 | |
Michael Sean Stiewe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3237 S 16th St, Milwaukee, WI 53215 Phone: 414-647-5043 |